Aetna will not pay commissions to agents and brokers who enroll new members in 123 Medicare Advantage plans across 33 states for the 2027 plan year, according to the notice the CVS Health subsidiary distributed to third-party marketing organizations last week.
The freeze covers policies in nearly 780 counties, with about one-fifth of those located in Georgia. Aetna will also not compensate agents and brokers for new enrollments in standalone Medicare Part D prescription drug plans, Modern Healthcare reported.
Timing is what matters for enrollees. Medicare open enrollment runs from October 15 through December 7. A senior who calls a broker this fall may find that the person on the phone earns nothing for placing them in one of these plans, and that is not something the broker is required to volunteer.
The Difference Between a Frozen Commission and a Canceled Plan
Several things stay exactly the same, and stating them plainly avoids unnecessary alarm.
The plans are not being canceled. Benefits do not change because of a commission decision. Anyone already enrolled in one of these 123 plans keeps their coverage, their network, and their drug formulary. Existing members are not being dropped, and renewal compensation is a separate question from new-enrollment compensation.
What changes is the distribution channel? Brokers are the route through which a large share of Medicare enrollees select a plan, and an unpaid broker has no financial incentive to present a plan or spend time explaining it. The practical effect is that certain plans quietly disappear from the menu a consumer is shown, without any public announcement that they have become harder to find.
Insurers have been doing this since 2024. Aetna cut commissions on more than two dozen Medicare Advantage plans in 10 markets that year, and Aetna, Cigna, and Elevance all trimmed broker payments during subsequent enrollment periods, sometimes mid-season. The pattern sits inside a wider retrenchment, with major carriers exiting counties and trimming plan portfolios as medical costs rose faster than payment rates. Read together, plan exits, and commission freezes describe the same strategy at different intensities: one removes a plan from the market, the other removes it from the sales conversation while leaving it technically available.
What the Compensation Rules Do and Do Not Reveal
Federal rules cap what carriers may pay, and understanding those caps puts a zero in context.
The Centers for Medicare and Medicaid Services released its 2027 fair market value figures on June 1. In most states, published compensation schedules set the initial Medicare Advantage commission at $725 per member per year, with renewals at $363. A few markets are higher, at $816 in Connecticut, Pennsylvania, and Washington, D.C., and $902 in California and New Jersey. Standalone Part D commissions rose to $130 initial and $65 renewal, a 14 percent increase and the largest in the schedule. Carriers may pay any amount up to those ceilings, or nothing at all.
Read against those caps, a plan paying zero is making a statement. When an insurer wants a plan to grow, it pays at or near the maximum. When it wants a plan to shrink quietly, compensation goes flat or disappears.
There is less public visibility into which plans those are than a shopper might hope. CMS publishes a file of the amounts companies pay independent agents to sell Medicare drug and health plans, and organizations had to submit their 2027 compensation schedules to the agency by July 31. But the more granular reporting introduced for 2027, which lets plans flag where they pay zero and report actual amounts by plan benefit package, is voluntary and not publicly posted. It is submitted through an internal CMS system and is intended to inform future policy rather than to guide consumers.
The broader rules are also in flux. A federal court vacated portions of the agency's 2025 compensation rule, and CMS reverted to the earlier methodology when calculating 2027 limits. Separately, the contract year 2027 final rule rolled back marketing safeguards introduced in 2023, including the 48-hour waiting period between a signed scope of appointment and a marketing appointment, with most changes taking effect on October 1.
The Enrollees Who Should Take This Seriously
The people with the most at stake are Medicare beneficiaries in the affected counties who use a broker or a call center to choose coverage, particularly first-time enrollees turning 65 and anyone whose current plan is changing enough to force a decision.
Beneficiaries with complex needs face the sharpest version of the problem. Someone managing multiple chronic conditions, taking specialty medications, or seeing a specific specialist has the most to lose from a narrowed menu, because the plan that fits their situation may be one nobody is being paid to mention.
The countermeasures are straightforward and free. State Health Insurance Assistance Programs provide unbiased counseling in every state, and their counselors are not paid on commission. The federal Medicare plan finder allows side-by-side comparison of every plan available in a county, including ones a broker may not raise. Anyone working with an agent can ask directly whether they are compensated for the plans being presented and whether any available plans were excluded from the comparison.
Two verification steps matter regardless of who does the shopping. Confirm that your specific doctors are in-network for the coming year, not the current one, and run your actual prescription list through the plan's formulary, since networks and drug lists change annually.
This is a business decision rather than a health decision, and it does not indicate anything about the quality of the affected plans. Some of them may be strong fits for the right enrollee. What it does is make comparison shopping less automatic than it looks, and it shifts more of the work onto the person choosing coverage rather than the person selling it.
What is not yet public is which specific 123 plans are affected, whether other major carriers will announce similar freezes before open enrollment opens, and how many beneficiaries sit in the affected counties. MedicalDaily will report as carriers finalize their 2027 positions.
Key Questions Answered
What did Aetna announce? That it will not pay commissions to agents and brokers for new enrollments in 123 Medicare Advantage plans across 33 states for the 2027 plan year, and will not pay compensation for new standalone Part D enrollments.
How many counties are affected? Nearly 780, with about one-fifth of them in Georgia.
Are these plans being canceled? No. The plans continue, and benefits do not change as a result of a commission decision. Current members keep their coverage.
How does this affect me if I use a broker? A broker earns nothing for placing you in one of these plans, so they may not present them. Ask directly whether any available plans were omitted from your comparison.
Can I look up which plans have no cost? Not easily. CMS publishes a general file on agent compensation, but detailed plan-level reporting that flags zero-commission plans is voluntary and not posted publicly.
Where can I get unbiased help? State Health Insurance Assistance Programs offer free counseling in every state, and counselors are not paid on commission.
What should I verify before choosing a plan? That your doctors are in-network for the coming plan year and that your actual prescriptions appear on the plan's formulary, since both change annually.
